Population pharmacokinetics. Theory and clinical application.
about
Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model ConstructionBasic Concepts in Population Modeling, Simulation, and Model-Based Drug DevelopmentBacktracking booze with Bayes--the retrospective interpretation of blood alcohol data.Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.Drug dosage individualization based on a random-effects linear model.Population pharmacokinetics: theory and practice.Clinical pharmacology = disease progression + drug actionNonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy.Population pharmacokinetics I: background, concepts, and models.Population pharmacokinetics II: estimation methods.Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies.Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.Population pharmacokinetics/pharmacodynamics of anestheticsOverview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Bayesian clinical trials in actionPopulation pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimenSparse data analysis.Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.When it is better to estimate a slope with only one point.Drug Development of Therapeutic Monoclonal Antibodies.Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach.Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.Population pharmacokinetics.Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models.Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.Pharmacokinetics and milk discard times of pirlimycin after intramammary infusion: a population approach.Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid Algorithm.Ethanol kinetics: extent of error in back extrapolation procedures.Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis.Estimating individual benefits of medical or behavioral treatments in severely ill patients.Application of population pharmacokinetics to the optimization of theophylline therapy.Nonparametric expectation maximization population modeling of ganciclovir.Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models
P2860
Q28550166-90330607-927E-4B68-A11D-91F9E337E10AQ29013931-C354C413-D2E3-4ABC-996C-503EC774D023Q33530900-917A816A-B068-4CCD-ADE1-45721CA35794Q33978372-5F966BF0-6BEA-46FB-B6B3-5C9374C43611Q33979807-B56ACDBE-DC81-4128-AD0F-B6C14F0C20E0Q34261199-ED7766B6-1EFE-46B5-9158-0F77D59C9E0EQ34358724-F74BE7FC-0BE3-45F6-95EB-1CBFD46D43E4Q34953659-6680F0B6-D388-450F-A614-6304777CF592Q35814454-DA988433-7A01-47D6-9339-567C2E6C364FQ35870696-1EF78DC7-216E-44E1-B839-1789A7C35B5CQ35887615-AC7806B7-BD48-4872-AF7C-3B1025305240Q35928858-1E1550E8-34E6-411B-A8DD-AF10C287BFC8Q36055374-9718130B-3680-455D-B0ED-C7532EEACC6AQ36341601-990C8AFB-9993-462D-82F2-074E013B5C8BQ36388088-F269852A-A7BC-4257-8F5B-0B5BF5D98783Q36392556-CC870431-CAEB-4D3C-ADED-3B1B00E885D9Q36536401-31BC9FD3-9559-49C7-8C9F-B1F0906F36A6Q36765409-90D2F1F9-B87D-4992-81AD-547A18ADABB3Q37118509-EF6B569A-209D-4284-AE5A-DD45B648E414Q37335239-3C0755E5-DCEF-4135-8998-B70293CFBF76Q38876360-8A8D8CCC-5197-47B9-A276-DAB351ACEAC1Q39033840-A606AB66-EAC3-4348-8B57-D1ECB9A1B1E5Q39235496-D8F477C3-6358-43C9-BD6B-360EE9F9E6BFQ39334142-87E83F44-824D-42C4-B7C4-1A822BD6A024Q39571946-639DBCD7-13CF-4807-B8C0-32380EDC68ECQ39669644-7E5F6BB9-3102-42B0-81D1-82388F429D33Q39864822-54A98A80-DFCD-41CE-805A-227420859394Q40481176-619B8B29-ED15-4B0C-872B-3C5CCAF4949BQ40815580-EB7F46FF-6D54-4610-9A4C-94DE2D982C3AQ42599663-C431D3F3-611F-45CB-97D8-3D19A1D96D97Q43154040-DB838D0E-F171-4CF6-9758-C0A8DA25D1DCQ43224391-4B87CD31-8E54-4E4F-9007-5C7FA5CC8C77Q44738504-DFAB04A3-0125-4ECC-9C42-833411245B92Q47630719-181F4201-F085-4416-8074-C130CA3F3F28Q51009490-C58F26E1-5A0F-47D9-B025-969F5B0CF782Q52307595-1DF431DA-A7C6-4EE9-851A-330E56C96134Q57491919-80C8D83B-76C5-4192-B8D3-22AC058C08A2
P2860
Population pharmacokinetics. Theory and clinical application.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Population pharmacokinetics. Theory and clinical application.
@en
Population pharmacokinetics. Theory and clinical application.
@nl
type
label
Population pharmacokinetics. Theory and clinical application.
@en
Population pharmacokinetics. Theory and clinical application.
@nl
prefLabel
Population pharmacokinetics. Theory and clinical application.
@en
Population pharmacokinetics. Theory and clinical application.
@nl
P2093
P1476
Population pharmacokinetics. Theory and clinical application.
@en
P2093
P304
P356
10.2165/00003088-198611050-00004
P577
1986-09-01T00:00:00Z
P6179
1028398723